People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Pharmaceuticals, Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eliem Therapeutics, Inc. | — | Pharmaceuticals | Series D+ | $253.2M | $1.3B | 2020 |
| Unum Therapeutics Inc. | — | Biotechnology | Series D+ | $220.5M | $4.3B | 2015 |
| Halda Therapeutics, LLC | — | Pharma | Series D+ | $197.9M | $1.3B | 2021 |
| Arvinas, Inc. | — | Biotechnology | Series C | $129.1M | $1.3B | 2015 |
Liam Ratcliffe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Liam Ratcliffe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ANDREW LEVIN | 2 | 17 |
| Tim Shannon | 2 | 9 |
| Bruce Booth | 1 | 12 |
| Kush Parmar | 1 | 10 |
| Ben Auspitz | 1 | 9 |
| Stephen Squinto | 1 | 8 |
| Sean Cassidy | 1 | 7 |
| Adam Rosenberg | 1 | 6 |
| Stephen Thomas | 1 | 5 |
| Charles Wilson | 1 | 5 |
| Arjun Goyal | 1 | 5 |
| Scott Phillips | 1 | 5 |
| Nandita Shangari | 1 | 4 |
| Jonathan Soderstrom | 1 | 3 |
| Rebecca Luse | 1 | 3 |
| Julio Vega | 1 | 3 |
| Erin Lavelle | 1 | 3 |
| Aoife Brennan | 1 | 2 |
| Brad Margus | 1 | 2 |
| Liam D. Ratcliffe | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.